Project overview $500,000 funding from Solving Kids Cancer, $680,000 funding from BMS and $100,000 from EUSA Pharma. Juliet Gray is international lead / chief investigator Staff Lead researchers Professor Juliet Gray Professor Research interests Fc modification of monoclonal antibodies to improve effector function Connect with Juliet Email: [email protected] Research outputs